Accelerated CMC Workflows to enable Speed to Clinic in the COVID ‐19 era: A multi‐company view from the Biopharmaceutical Industry

This article provides an in-depth analysis of this data, ultimately highlighting an industry perspective of how biopharmaceutical companies can sustainably adopt new approaches to therapeutic protein development and production.This article is protected by copyright. All rights reserved.

Source: Biotechnology Progress - December 23, 2022 Category: Biotechnology Authors: Matthew F. Higgins, Nicholas Abu ‐Absi, Elena Gontarz, Ingo H. Gorr, Klaus Kaiser, Pramthesh Patel, Frank Ritacco, Patrick Sheehy, Bala Thangaraj Kumaar, Tony Gill Tags: REVIEW Source Type: research